These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 10221165)

  • 1. Prion protein and species barriers in the transmissible spongiform encephalopathies.
    Priola SA
    Biomed Pharmacother; 1999; 53(1):27-33. PubMed ID: 10221165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation influences cross-species formation of protease-resistant prion protein.
    Priola SA; Lawson VA
    EMBO J; 2001 Dec; 20(23):6692-9. PubMed ID: 11726505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.
    Priola SA; Chabry J; Chan K
    J Virol; 2001 May; 75(10):4673-80. PubMed ID: 11312338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formation of protease-resistant prion protein in cell-free systems.
    Caughey B
    Curr Issues Mol Biol; 2000 Jul; 2(3):95-101. PubMed ID: 11471561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform.
    Vorberg I; Groschup MH; Pfaff E; Priola SA
    J Virol; 2003 Feb; 77(3):2003-9. PubMed ID: 12525634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of chimaeric murine/ovine PrP (A136H154Q171) in transgenic mice facilitates transmission and differentiation of ruminant prions.
    Griffiths PC; Plater JM; Chave A; Jayasena D; Tout AC; Rice PB; Vickery CM; Spiropoulos J; Stack MJ; Windl O
    J Gen Virol; 2013 Nov; 94(Pt 11):2577-2586. PubMed ID: 23761404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting interactions between prion protein isoforms.
    Caughey B; Baron GS
    Biochem Soc Trans; 2002 Aug; 30(4):565-9. PubMed ID: 12196138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prions of ruminants show distinct splenotropisms in an ovine transgenic mouse model.
    Baron T; Bencsik A; Morignat E
    PLoS One; 2010 Apr; 5(4):e10310. PubMed ID: 20436680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ formation of protease-resistant prion protein in transmissible spongiform encephalopathy-infected brain slices.
    Bessen RA; Raymond GJ; Caughey B
    J Biol Chem; 1997 Jun; 272(24):15227-31. PubMed ID: 9182546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between heterologous forms of prion protein: binding, inhibition of conversion, and species barriers.
    Horiuchi M; Priola SA; Chabry J; Caughey B
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5836-41. PubMed ID: 10811921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single hamster PrP amino acid blocks conversion to protease-resistant PrP in scrapie-infected mouse neuroblastoma cells.
    Priola SA; Chesebro B
    J Virol; 1995 Dec; 69(12):7754-8. PubMed ID: 7494285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species barriers in prion diseases--brief review.
    Moore RA; Vorberg I; Priola SA
    Arch Virol Suppl; 2005; (19):187-202. PubMed ID: 16355873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for studying prion protein (PrP) metabolism and the formation of protease-resistant PrP in cell culture and cell-free systems. An update.
    Caughey B; Raymond GJ; Priola SA; Kocisko DA; Race RE; Bessen RA; Lansbury PT; Chesebro B
    Mol Biotechnol; 1999 Nov; 13(1):45-55. PubMed ID: 10934521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of beta-strand and alpha-helix secondary structure in normal prion protein inhibits formation of its protease-resistant isoform.
    Vorberg I; Chan K; Priola SA
    J Virol; 2001 Nov; 75(21):10024-32. PubMed ID: 11581371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cells expressing anchorless prion protein are resistant to scrapie infection.
    McNally KL; Ward AE; Priola SA
    J Virol; 2009 May; 83(9):4469-75. PubMed ID: 19225008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical transmissible spongiform encephalopathies (TSEs) in ruminants.
    Baron T; Biacabe AG; Arsac JN; Benestad S; Groschup MH
    Vaccine; 2007 Jul; 25(30):5625-30. PubMed ID: 17126958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro.
    Lawson VA; Priola SA; Meade-White K; Lawson M; Chesebro B
    J Biol Chem; 2004 Apr; 279(14):13689-95. PubMed ID: 14736880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of scrapie strain glycoform variation.
    Vorberg I; Priola SA
    J Biol Chem; 2002 Sep; 277(39):36775-81. PubMed ID: 12138171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.